Artelo Biosciences (ARTL) Other Operating Expenses (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Other Operating Expenses of -$310000.0 for Q4 2025, up 16.89% year-over-year from -$265206.4 in Q4 2024, and up 6.63% quarter-over-quarter from -$332000.0 in Q3 2025.
Artelo Biosciences (ARTL) Other Operating Expenses (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Other Operating Expenses for 10 consecutive years, with -$310000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 16.89% year-over-year to -$310000.0; the TTM figure through Dec 2025 stood at -$1.2 million (up 7.65% YoY), while the FY2025 annual figure was -$1.2 million, up 7.65% from the prior year.
- Other Operating Expenses grew to -$310000.0 in Q4 2025 per ARTL's latest filing, from -$332000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $226042.0 in Q2 2021 and bottomed at -$785133.0 in Q3 2021.
- Historically, Other Operating Expenses has averaged -$261584.5 across 3 years, with a median of -$310000.0 in 2025.
- Annual changes were most pronounced in 2021 — Other Operating Expenses retreated 25.53% — and 2025, when it climbed 17.0%.
- Artelo Biosciences' Other Operating Expenses stood at -$785133.0 in 2021, then jumped by 52.49% to -$373000.0 in 2024, then gained by 16.89% to -$310000.0 in 2025.
- Business Quant data shows ARTL's Other Operating Expenses at -$310000.0 in Q4 2025, -$332000.0 in Q3 2025, and -$249000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -310,000.00 |
| Sep 30, 2025 | -332,000.00 |
| Jun 30, 2025 | -249,000.00 |
| Mar 31, 2025 | -317,000.00 |
| Dec 31, 2024 | -373,000.00 |
| Sep 30, 2024 | -326,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Mar 31, 2024 | -309,000.00 |
| Aug 31, 2021 | -785,133.00 |
| May 31, 2021 | 226,042.00 |
| Feb 28, 2021 | 197,661.00 |
| May 31, 2020 | 303,524.00 |
| Feb 29, 2020 | 215,506.00 |
| Nov 30, 2019 | 266,351.00 |
| Aug 31, 2019 | 433,545.00 |
| May 31, 2019 | 354,281.00 |
| Feb 28, 2019 | 210,016.00 |
| Nov 30, 2018 | 167,363.00 |
| Aug 31, 2018 | 121,350.00 |
| May 31, 2018 | 236,375.00 |